Therefore, we performed a pan-cancer screening of CBX4 expression via the DiffExp module of TIMER which allows to compare differential expression of a gene of interest between tumors and adjacent normal tissues across the TCGA malignancies. This evidence concerns the gene CBX4 and cancer.